Cai Y et al. [205] investigated the potential mechanism of Sal in slowing the progression of AD and discovered that Sal can significantly ameliorate AD pathology by inhibiting the activation of NLRP3 inflammasomes and the release of downstream pro-inflammatory factors. This evidence concerns the gene NLRP3 and Alzheimer disease.